| ATCC 33387| Bacteroides corrodens| Bacteroides ureolyticus| Bacteroides ureolyticus Jackson and Goodman 1978 (Approved Lists 1980)| Campylobacter ureolyticus| Campylobacter ureolyticus (Jackson and Goodman 1978) Vandamme et al. 2010| CCUG 7319| DSM 20703| LMG 6451| LMG:6451| NCTC 10941
Gastroenteritis: Campylobacter ureolyticus, like other Campylobacter species, has been associated with gastroenteritis in humans. Symptoms of Campylobacter infection typically include diarrhea, abdominal cramps, fever, and, in some cases, nausea and vomiting.
Transmission: Campylobacter bacteria are often transmitted to humans through the consumption of contaminated food, especially undercooked poultry, unpasteurized milk, and untreated water. Direct contact with infected animals or their environment can also be a source of transmission.
Antibiotic Sensitivity: Campylobacter ureolyticus, similar to other Campylobacter species, can show varying degrees of antibiotic sensitivity. The choice of antibiotics for treatment may depend on the specific strain and its resistance profile.
Complications: In some cases, Campylobacter infections can lead to more severe complications, including bacteremia (presence of bacteria in the bloodstream) and the development of Guillain-BarrΓ© syndrome, a rare neurological disorder.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 0.31 | 1 | 113 | 0 | 114 | 39.1 | 30 | 38 | 1 | 113 | 11.1 %ile | 77.8 %ile | ||
biomesight | 11.61 | 0 | 10 | 2490 | 0 | 2724 | 300.6 | 50 | 1236.7 | 10 | 210 | 0 %ile | 98.2 %ile | |
thorne | 58.62 | 1 | 831 | 0 | 506 | 98.5 | 17 | 208.1 | 1 | 831 | 0 %ile | 100 %ile | ||
thryve | 15.25 | 0 | 10 | 4 | 14218 | 0 | 4302 | 529.1 | 64 | 1925 | 0 | 364 | 0 %ile | 100 %ile |
ubiome | 16.6 | 0 | 23 | 12 | 9119 | 0 | 4173 | 732.9 | 106 | 1755.1 | 0 | 900 | 0 %ile | 100 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
Thorne (20/80%ile) | 0 | 0 | 0 | 0 |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSight | 11.976 % | 0.026 % | 0.112 % | 343.0 | 2864 |
BiomeSightRdp | 15.625 % | 0.003 % | 0.002 % | 5.0 | 32 |
CerbaLab | 33.333 % | 0 % | % | 1.0 | 3 |
CosmosId | 3.125 % | 0.004 % | % | 1.0 | 32 |
es-xenogene | 3.448 % | 0.002 % | % | 1.0 | 29 |
SequentiaBiotech | 2.778 % | 0.011 % | % | 1.0 | 36 |
Thorne | 50 % | 0.01 % | 0.021 % | 45.0 | 90 |
Thryve | 13.304 % | 0.049 % | 0.185 % | 184.0 | 1383 |
uBiome | 16.54 % | 0.073 % | 0.176 % | 131.0 | 792 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.